IGC Pharma (IGC) Institutional Ownership $0.25 0.00 (0.00%) Closing price 10/23/2026 04:10 PM EasternExtended Trading$0.25 +0.01 (+2.03%) As of 05:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartEarningsNews and TrendsOwnershipSEC Filings Institutional Ownership Changes (13F Filings) for IGC Pharma (NYSEAMERICAN:IGC)CurrentInstitutional OwnershipPercentage3.87%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$175.93KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$198.09K Get IGC Insider Trade Alerts Want to know when executives and insiders are buying or selling IGC Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data IGC Institutional Buying and Selling by Quarter IGC Pharma Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2026Renaissance Technologies LLC483,975$127K0.0%-47.4%0.490% 2/13/2026State Street Corp200,799$57K0.0%+25.3%0.211% 2/12/2026Renaissance Technologies LLC919,641$259K0.0%-24.6%0.968% 11/17/2025Citadel Advisors LLC627,840$262K0.0%+131.7%0.683% 11/14/2025Virtu Financial LLC89,546$37K0.0%+91.0%0.097% 2/17/2025Squarepoint Ops LLC125,966$42K0.0%N/A0.163% 2/14/2025Northern Trust Corp113,407$38K0.0%+59.7%0.146% 2/12/2025Geode Capital Management LLC669,685$225K0.0%+19.0%0.865% 11/20/2024Virtu Financial LLC123,060$53K0.0%+164.7%0.159% 11/16/2024Geode Capital Management LLC562,969$240K0.0%+31.0%0.744% 10/29/2024Fullcircle Wealth LLC103,443$42K0.0%N/A0.137% IGC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IGC shares? During the previous two years, the following institutional investors and hedge funds held shares of IGC Pharma shares: Citadel Advisors LLC ($262K), Geode Capital Management LLC ($225K), Renaissance Technologies LLC ($127K), State Street Corp ($57K), Squarepoint Ops LLC ($42K), Fullcircle Wealth LLC ($42K), and Northern Trust Corp ($38K).Learn more on IGC Pharma's institutional investors. What percentage of IGC Pharma's stock is owned by institutional investors? 3.87% of IGC Pharma's stock is owned by institutional investors. Learn more on IGC's institutional investor holdings. Which institutional investors have been buying IGC Pharma's stock? The following institutional investors have purchased IGC Pharma's stock in the last 24 months: Citadel Advisors LLC ($356.87K), Geode Capital Management LLC ($239.86K), Squarepoint Ops LLC ($125.97K), Virtu Financial LLC ($119.22K), Fullcircle Wealth LLC ($103.44K), Northern Trust Corp ($42.38K), and State Street Corp ($40.59K). How much institutional buying is happening at IGC Pharma? Institutional investors have bought a total of 440,120 shares in the last 24 months. This purchase volume represents approximately $175.93K in transactions. Which of IGC Pharma's major shareholders have been selling company stock? The following institutional investors have sold IGC Pharma stock in the last 24 months: Renaissance Technologies LLC ($734.99K). How much institutional selling is happening at IGC Pharma? Institutional investors have sold a total of 734,990 shares in the last 24 months. This volume of shares sold represents approximately $198.09K in transactions. Related Companies Immunic Institutional Ownership Vivani Medical Institutional Ownership LENZ Therapeutics Institutional Ownership PolyPid Institutional Ownership ImmuCell Institutional Ownership Milestone Pharmaceuticals Institutional Ownership Neumora Therapeutics Institutional Ownership Aardvark Therapeutics Institutional Ownership Pelthos Therapeutics Institutional Ownership Nutriband Institutional Ownership Institutional ownership data for NYSEAMERICAN:IGC is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 5/14/2026. New 13F filings are added each quarter as they're published. From Our PartnersExecutive Order 14241 Unleashes Trump’s New DollarA landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredForget the AI predictions. Look at the incomeAI predictions are everywhere, but Tim Plaehn is focused on something concrete: income. He's found a small ...Investors Alley | SponsoredFinally… options made simpleIan Cooper once believed successful options trading meant endless chart-watching, complex strategies, and big ...TradeWins | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredElon says the ‘S’ wordElon Musk and Sam Altman have sued each other and feuded for years. Yet within days of one another, both men d...Paradigm Press | SponsoredElon Musk’s One Stock Retirement PlanStanley Druckenmiller once said you don't get rich diversifying into 50 mediocre assets - you get rich finding...Brownstone Research | Sponsored80 Days Until America's Rare Earth Supply Chain ShiftChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGC Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGC Pharma With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
